drugset / Trial / NCT07704372

Superoxide Dismutase Skin Spray for the Prevention of Acute Radiation Dermatitis in Head and Neck Cancer

NCT07704372

Phase 2 Not yet recruiting 140 enrolled West China Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

To evaluate the efficacy and safety of superoxide dismutase skin spray for the reducing the acute radiation dermatitis in patients with head and neck malignancies undergoing radiotherapy.

Timeline

Start
2026-07-15
Primary completion
2026-12-30
Completion
2027-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject ORGOTEIN Protein / enzyme biologic Topical

Indications